Answers are grounded in this paper and cite their sources.
Preclinical evaluation demonstrates targeted neuronal and mitochondrial ROS scavenging by dual-targeted Janus nanoparticles, suggesting a novel therapeutic strategy for cognitive impairment.
Cognitive Impairment Inspired by the Chinese myth of Nezha, the Janus “magic pill” shows an asymmetric structure: the Au domain with RVG peptide targets neurons, while the mSiO2 domain with TPP ligands homes to mitochondria, encapsulating vitamin B2. A mitochondrial boat floats on a neuronal surface, where ROS are scavenged as the pill approaches, symbolizing precision delivery and hierarchical targeting. More details can be found in the Research Article by Kai-Run Zhang, Xiaomin Li, Jun Gao, Yue-Hua Liu, and co-workers (DOI: 10.1002/adma.73920).
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: